Using chromatin immunoprecipitation (ChIP), both MyoD and SRF DNA-binding at the human ANK1-5 promoter were decreased in DMD patient myoblasts and myotubes (Fig 1C). This evidence concerns the gene MYOD1 and Duchenne muscular dystrophy.